new glp 1 drugs The GLP-1 Revolution: From Diabetes and Obesity to Alzheimer's and PCOS GLP-1 Agonists: A Comprehensive Overview

This medicine can cause life-threatening ketoacidosis (too much acid in the blood)

World Health Organization, Geneva Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035

After 2 weeks of treatment, the dose should be increased to 0.2 mg (100 l) three times daily

We further outline future perspectives such as hybrid multifunctional nanoplatforms, patient-specific redox profiling, and clinical pathways for regulatory approval

Cancer and cure: A critical analysis

Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity